Department of Paediatric Gastroenterology and Hepatology and Nutrition, University Hospitals Leuven, Herestraat 49. 3000 KU, Louvain, Belgium.
J Gastroenterol. 2022 Sep;57(9):619-629. doi: 10.1007/s00535-022-01903-6. Epub 2022 Jul 14.
As extra-intestinal manifestations (EIMs) are frequent in inflammatory bowel disease (IBD) and affect morbidity and sometimes even mortality, vigilance in the surveillance of EIMs and installing the appropriate treatment are essential. Data on renal manifestations in patients with IBD are however rare. Nevertheless, up to 5-15% of adult patients with IBD will develop chronic kidney disease over time. The pathophysiology of renal involvement in patients with IBD is complex and poorly understood, with a wide range of renal disorders affecting the glomeruli and/or the tubular structure. Furthermore, medication used to treat IBD can be potentially nephrotoxic and metabolic complication due to the disease itself can furthermore cause renal damage. The aim of this systematic review is to provide an overview of the existing data in literature on these renal manifestations and complications in patients with IBD.
由于肠道外表现(EIMs)在炎症性肠病(IBD)中很常见,并且会影响发病率,有时甚至会影响死亡率,因此对 EIMs 的监测和适当的治疗至关重要。然而,关于 IBD 患者的肾脏表现的数据却很少。尽管如此,随着时间的推移,多达 5-15%的成年 IBD 患者会发展为慢性肾脏病。IBD 患者肾脏受累的病理生理学复杂且尚未完全了解,广泛的肾脏疾病会影响肾小球和/或管状结构。此外,用于治疗 IBD 的药物可能具有潜在的肾毒性,并且由于疾病本身引起的代谢并发症也会导致肾脏损伤。本系统综述的目的是对文献中关于 IBD 患者这些肾脏表现和并发症的现有数据进行综述。